Cellebrite DI (CLBT) Shares Outstanding (Diluted Average) (2019 - 2025)

Cellebrite DI (CLBT) has 6 years of Shares Outstanding (Diluted Average) data on record, last reported at $249.9 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 19.3% year-over-year to $249.9 million; the TTM value through Dec 2025 reached $249.9 million, up 19.3%, while the annual FY2025 figure was $249.9 million, 19.3% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $249.9 million in Q4 2025 per CLBT's latest filing, up from $209.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $249.9 million in Q4 2025 and bottomed at $161.5 million in Q4 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $201.3 million, with a median of $195.4 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Diluted Average): soared 30.59% in 2021, then fell 2.68% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $161.5 million in 2021, then increased by 20.96% to $195.4 million in 2022, then dropped by 2.68% to $190.2 million in 2023, then rose by 10.16% to $209.5 million in 2024, then increased by 19.3% to $249.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $249.9 million in Q4 2025, $209.5 million in Q4 2024, and $190.2 million in Q4 2023.